MCK vs CAH stock comparison
Mckesson vs. Cardinal Health · data as of November 13, 2026
Mckesson (MCK) has a market value of about $127.3B, Cardinal Health (CAH) about $65.0B. Over their latest twelve months Mckesson had revenue of $418.8B and Cardinal Health $257.8B.
On our five checks Cardinal Health scores higher: 3.4 out of 5 (good) against 3.0 (average).
By area, the stronger company is Cardinal Health on value.
Mckesson is cheaper on earnings (P/E 28.4 vs. 36.4).
Mckesson leads on 9 of the compared lines and Cardinal Health on 10.
Side by side
| MCK | CAH | |
|---|---|---|
| Size and price | ||
| Market cap | $127.3B | $65.0B |
| Share price | $1,102.81 | $281.10 |
| Score | ||
| Overall score (of 5) | 3.0 | 3.4 |
| Value | 1 | 3 |
| Future growth | 3 | 3 |
| Track record | 3 | 3 |
| Financial health | 3 | 3 |
| Shareholder returns | 5 | 5 |
| Valuation | ||
| P/E (TTM) | 28.4 | 36.4 |
| Forward P/E | 21.7 | 20.5 |
| Price / free cash flow | 17.9 | 13.3 |
| Price / sales | 0.3 | 0.3 |
| EV / EBITDA | 17.7 | 18.7 |
| PEG | — | 1.28 |
| DCF value vs. price | −4% | +16% |
| Business | ||
| Revenue | $418.8B | $257.8B |
| Net income | $4.7B | $1.8B |
| Free cash flow | $7.1B | $4.9B |
| Net margin | 1.1% | 0.7% |
| Gross margin (5-yr avg.) | 4.2% | 3.5% |
| ROIC (5-yr avg.) | 59.3% | 21.8% |
| Growth | ||
| Revenue growth (1 yr) | 12.4% | 14.2% |
| Revenue growth (5 yrs, per year) | 11.1% | 9.4% |
| EPS growth (5 yrs, per year) | — | 28.3% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$4.6B | -$3.6B |
| Dividend yield | 0.34% | 0.73% |
| Shareholder yield | 4.1% | 2.8% |
| Analysts | ||
| Upside to average target | +4% | +5% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MCK TTM to September 30, 2026, CAH TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Mckesson or Cardinal Health?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Cardinal Health scores 3.4 out of 5 and Mckesson 3.0; the table shows where each one is stronger.
Is Mckesson cheaper than Cardinal Health?
On trailing earnings, Mckesson trades at a P/E of 28.4 and Cardinal Health at 36.4, so Mckesson is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Mckesson or Cardinal Health?
Over five years Mckesson grew revenue about 11.1% a year and Cardinal Health about 9.4% a year.
Which pays a higher dividend?
Mckesson yields 0.34% and Cardinal Health 0.73%.
Full Mckesson analysis → Full Cardinal Health analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.